| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 3.33e-07 | 12 | 24 | 3 | GO:0048407 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.24e-05 | 46 | 24 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | growth factor binding | 8.39e-04 | 156 | 24 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | protease binding | 1.29e-03 | 181 | 24 | 3 | GO:0002020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.44e-03 | 188 | 24 | 3 | GO:0005201 | |
| GeneOntologyBiologicalProcess | sensory perception of sound | 3.52e-06 | 198 | 25 | 5 | GO:0007605 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 8.63e-06 | 238 | 25 | 5 | GO:0050954 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 1.67e-05 | 129 | 25 | 4 | GO:0042472 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 3.35e-05 | 154 | 25 | 4 | GO:0042471 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 7.81e-05 | 377 | 25 | 5 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 7.91e-05 | 378 | 25 | 5 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 8.01e-05 | 379 | 25 | 5 | GO:0045229 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.04e-04 | 76 | 25 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | skin morphogenesis | 1.47e-04 | 15 | 25 | 2 | GO:0043589 | |
| GeneOntologyBiologicalProcess | embryo development | 2.01e-04 | 1437 | 25 | 8 | GO:0009790 | |
| GeneOntologyBiologicalProcess | inner ear development | 2.28e-04 | 253 | 25 | 4 | GO:0048839 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 3.46e-04 | 114 | 25 | 3 | GO:0045824 | |
| GeneOntologyBiologicalProcess | ear development | 3.59e-04 | 285 | 25 | 4 | GO:0043583 | |
| GeneOntologyBiologicalProcess | auditory receptor cell stereocilium organization | 4.50e-04 | 26 | 25 | 2 | GO:0060088 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 4.95e-04 | 561 | 25 | 5 | GO:0048568 | |
| GeneOntologyBiologicalProcess | auditory receptor cell morphogenesis | 6.42e-04 | 31 | 25 | 2 | GO:0002093 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 7.21e-04 | 343 | 25 | 4 | GO:0090596 | |
| GeneOntologyBiologicalProcess | skeletal system development | 7.51e-04 | 615 | 25 | 5 | GO:0001501 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 7.86e-04 | 351 | 25 | 4 | GO:0048562 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 7.86e-04 | 151 | 25 | 3 | GO:0002832 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 1.01e-03 | 375 | 25 | 4 | GO:0007162 | |
| GeneOntologyBiologicalProcess | auditory receptor cell development | 1.07e-03 | 40 | 25 | 2 | GO:0060117 | |
| GeneOntologyBiologicalProcess | replacement ossification | 1.24e-03 | 43 | 25 | 2 | GO:0036075 | |
| GeneOntologyBiologicalProcess | endochondral ossification | 1.24e-03 | 43 | 25 | 2 | GO:0001958 | |
| GeneOntologyBiologicalProcess | microtubule-based process | 1.37e-03 | 1058 | 25 | 6 | GO:0007017 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 1.47e-03 | 47 | 25 | 2 | GO:0060351 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 3.30e-07 | 12 | 25 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 3.30e-07 | 12 | 25 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen type I trimer | 1.37e-06 | 2 | 25 | 2 | GO:0005584 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.98e-06 | 21 | 25 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | supramolecular fiber | 4.56e-05 | 1179 | 25 | 8 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 4.79e-05 | 1187 | 25 | 8 | GO:0099081 | |
| GeneOntologyCellularComponent | collagen trimer | 1.55e-04 | 88 | 25 | 3 | GO:0005581 | |
| GeneOntologyCellularComponent | microtubule | 3.68e-04 | 533 | 25 | 5 | GO:0005874 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 6.07e-04 | 332 | 25 | 4 | GO:0005788 | |
| GeneOntologyCellularComponent | midbody | 2.29e-03 | 222 | 25 | 3 | GO:0030496 | |
| GeneOntologyCellularComponent | stereocilium | 3.07e-03 | 69 | 25 | 2 | GO:0032420 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.38e-03 | 530 | 25 | 4 | GO:0062023 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 3.77e-03 | 899 | 25 | 5 | GO:0099513 | |
| GeneOntologyCellularComponent | stereocilium bundle | 4.00e-03 | 79 | 25 | 2 | GO:0032421 | |
| GeneOntologyCellularComponent | extracellular matrix | 7.19e-03 | 656 | 25 | 4 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 7.27e-03 | 658 | 25 | 4 | GO:0030312 | |
| HumanPheno | Joint subluxation | 5.37e-07 | 31 | 12 | 4 | HP:0032153 | |
| HumanPheno | Neonatal short-limb short stature | 3.58e-06 | 14 | 12 | 3 | HP:0008921 | |
| HumanPheno | Biconcave flattened vertebrae | 5.09e-06 | 2 | 12 | 2 | HP:0003321 | |
| HumanPheno | Absent ossification of calvaria | 5.09e-06 | 2 | 12 | 2 | HP:0005623 | |
| HumanPheno | Severe generalized osteoporosis | 5.09e-06 | 2 | 12 | 2 | HP:0005897 | |
| HumanPheno | Femoral bowing present at birth, straightening with time | 5.09e-06 | 2 | 12 | 2 | HP:0005005 | |
| HumanPheno | Short limb dwarfism | 9.48e-06 | 19 | 12 | 3 | HP:0003505 | |
| HumanPheno | Generalized osteoporosis | 1.11e-05 | 20 | 12 | 3 | HP:0040160 | |
| HumanPheno | Dwarfism | 1.30e-05 | 21 | 12 | 3 | HP:0001516 | |
| HumanPheno | Popcorn calcification | 1.52e-05 | 3 | 12 | 2 | HP:6000871 | |
| HumanPheno | Dentinogenesis imperfecta | 1.72e-05 | 23 | 12 | 3 | HP:0000703 | |
| HumanPheno | Abnormal pulmonary valve physiology | 2.08e-05 | 163 | 12 | 5 | HP:0031654 | |
| HumanPheno | Biconcave vertebral bodies | 2.23e-05 | 25 | 12 | 3 | HP:0004586 | |
| HumanPheno | Abnormal dentin morphology | 2.52e-05 | 26 | 12 | 3 | HP:0010299 | |
| HumanPheno | Pulmonic regurgitation | 2.83e-05 | 27 | 12 | 3 | HP:0010444 | |
| HumanPheno | Bowing of limbs due to multiple fractures | 3.04e-05 | 4 | 12 | 2 | HP:0003023 | |
| HumanPheno | Abnormality of habitus | 3.54e-05 | 87 | 12 | 4 | HP:0010718 | |
| HumanPheno | Gracile long bones | 3.87e-05 | 89 | 12 | 4 | HP:0003061 | |
| HumanPheno | Slender long bone | 3.87e-05 | 89 | 12 | 4 | HP:0003100 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 3.91e-05 | 30 | 12 | 3 | HP:0005743 | |
| HumanPheno | Basilar impression | 5.07e-05 | 5 | 12 | 2 | HP:0005758 | |
| HumanPheno | Bell-shaped thorax | 5.24e-05 | 33 | 12 | 3 | HP:0001591 | |
| HumanPheno | Abnormal pulmonary valve morphology | 5.35e-05 | 198 | 12 | 5 | HP:0001641 | |
| HumanPheno | Crumpled long bones | 7.59e-05 | 6 | 12 | 2 | HP:0006367 | |
| HumanPheno | Abnormal tibia morphology | 8.00e-05 | 107 | 12 | 4 | HP:0002992 | |
| HumanPheno | Decreased skull ossification | 8.71e-05 | 39 | 12 | 3 | HP:0004331 | |
| HumanPheno | Disproportionate tall stature | 1.01e-04 | 41 | 12 | 3 | HP:0001519 | |
| HumanPheno | Tibial bowing | 1.01e-04 | 41 | 12 | 3 | HP:0002982 | |
| HumanPheno | Otosclerosis | 1.06e-04 | 7 | 12 | 2 | HP:0000362 | |
| HumanPheno | Molluscoid pseudotumors | 1.06e-04 | 7 | 12 | 2 | HP:0000993 | |
| HumanPheno | Juvenile aseptic necrosis | 1.17e-04 | 43 | 12 | 3 | HP:0100323 | |
| HumanPheno | Increased susceptibility to fractures | 1.22e-04 | 235 | 12 | 5 | HP:0002659 | |
| HumanPheno | Soft skin | 1.25e-04 | 44 | 12 | 3 | HP:0000977 | |
| HumanPheno | Mitral valve prolapse | 1.38e-04 | 123 | 12 | 4 | HP:0001634 | |
| HumanPheno | Arterial rupture | 1.41e-04 | 8 | 12 | 2 | HP:0025019 | |
| HumanPheno | Generalized joint hypermobility | 1.63e-04 | 48 | 12 | 3 | HP:0002761 | |
| HumanPheno | Thin ribs | 2.07e-04 | 52 | 12 | 3 | HP:0000883 | |
| HumanPheno | Joint laxity | 2.45e-04 | 55 | 12 | 3 | HP:0001388 | |
| HumanPheno | Abnormal mitral valve morphology | 2.68e-04 | 146 | 12 | 4 | HP:0031477 | |
| HumanPheno | Abnormal epiphysis morphology | 2.74e-04 | 279 | 12 | 5 | HP:0005930 | |
| HumanPheno | Multiple rib fractures | 2.77e-04 | 11 | 12 | 2 | HP:0006640 | |
| HumanPheno | Protrusio acetabuli | 3.91e-04 | 13 | 12 | 2 | HP:0003179 | |
| HumanPheno | Slender build | 4.20e-04 | 66 | 12 | 3 | HP:0001533 | |
| HumanPheno | Recurrent joint dislocation | 4.56e-04 | 14 | 12 | 2 | HP:0031869 | |
| HumanPheno | Severe hearing impairment | 4.56e-04 | 14 | 12 | 2 | HP:0012714 | |
| HumanPheno | Soft, doughy skin | 4.56e-04 | 14 | 12 | 2 | HP:0001027 | |
| HumanPheno | Aortic dilatation | 4.59e-04 | 168 | 12 | 4 | HP:0001724 | |
| HumanPheno | Aortic aneurysm | 4.59e-04 | 168 | 12 | 4 | HP:0004942 | |
| HumanPheno | Coxa vara | 4.59e-04 | 68 | 12 | 3 | HP:0002812 | |
| HumanPheno | Muscle flaccidity | 5.25e-04 | 15 | 12 | 2 | HP:0010547 | |
| HumanPheno | Osteoporosis | 5.51e-04 | 324 | 12 | 5 | HP:0000939 | |
| HumanPheno | Atypical scarring of skin | 5.89e-04 | 74 | 12 | 3 | HP:0000987 | |
| HumanPheno | Abnormal stapes morphology | 6.78e-04 | 17 | 12 | 2 | HP:0008628 | |
| HumanPheno | Platybasia | 6.78e-04 | 17 | 12 | 2 | HP:0002691 | |
| HumanPheno | Decreased calvarial ossification | 6.78e-04 | 17 | 12 | 2 | HP:0005474 | |
| HumanPheno | Hallux valgus | 7.41e-04 | 80 | 12 | 3 | HP:0001822 | |
| HumanPheno | Multiple prenatal fractures | 7.62e-04 | 18 | 12 | 2 | HP:0005855 | |
| HumanPheno | Abnormal atrioventricular valve morphology | 7.87e-04 | 350 | 12 | 5 | HP:0006705 | |
| HumanPheno | Abnormality of the epiphysis of the femoral head | 8.25e-04 | 83 | 12 | 3 | HP:0010574 | |
| HumanPheno | Abnormal femoral epiphysis morphology | 9.16e-04 | 86 | 12 | 3 | HP:0006499 | |
| HumanPheno | Joint stiffness | 9.25e-04 | 202 | 12 | 4 | HP:0001387 | |
| HumanPheno | Spondylolisthesis | 9.44e-04 | 20 | 12 | 2 | HP:0003302 | |
| HumanPheno | Femoral hernia | 9.44e-04 | 20 | 12 | 2 | HP:0100541 | |
| HumanPheno | Shoulder dislocation | 9.44e-04 | 20 | 12 | 2 | HP:0003834 | |
| HumanPheno | Abnormal knee physiology | 9.47e-04 | 87 | 12 | 3 | HP:0034670 | |
| HumanPheno | Pes planus | 9.55e-04 | 365 | 12 | 5 | HP:0001763 | |
| HumanPheno | Deviation of the hallux | 9.79e-04 | 88 | 12 | 3 | HP:0010051 | |
| HumanPheno | Abnormal epiphyseal ossification | 9.79e-04 | 88 | 12 | 3 | HP:0010656 | |
| HumanPheno | Abnormal hallux morphology | 1.11e-03 | 212 | 12 | 4 | HP:0001844 | |
| HumanPheno | Abnormal femoral head morphology | 1.11e-03 | 92 | 12 | 3 | HP:0003368 | |
| HumanPheno | Avascular necrosis | 1.11e-03 | 92 | 12 | 3 | HP:0010885 | |
| HumanPheno | Abnormal acetabulum morphology | 1.11e-03 | 92 | 12 | 3 | HP:0003170 | |
| HumanPheno | Coxa valga | 1.11e-03 | 92 | 12 | 3 | HP:0002673 | |
| HumanPheno | Abnormal heart valve morphology | 1.15e-03 | 588 | 12 | 6 | HP:0001654 | |
| HumanPheno | Vascular dilatation | 1.17e-03 | 215 | 12 | 4 | HP:0002617 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 1.19e-03 | 94 | 12 | 3 | HP:0006500 | |
| HumanPheno | High myopia | 1.19e-03 | 94 | 12 | 3 | HP:0011003 | |
| HumanPheno | Enlarged thorax | 1.19e-03 | 94 | 12 | 3 | HP:0100625 | |
| HumanPheno | Abnormality of skull ossification | 1.19e-03 | 94 | 12 | 3 | HP:0002703 | |
| HumanPheno | Convex nasal ridge | 1.22e-03 | 95 | 12 | 3 | HP:0000444 | |
| HumanPheno | Enchondroma | 1.25e-03 | 23 | 12 | 2 | HP:0030038 | |
| HumanPheno | Abnormal foramen magnum morphology | 1.25e-03 | 23 | 12 | 2 | HP:0002699 | |
| HumanPheno | Upper extremity joint dislocation | 1.26e-03 | 96 | 12 | 3 | HP:0030310 | |
| HumanPheno | Joint dislocation | 1.29e-03 | 390 | 12 | 5 | HP:0001373 | |
| HumanPheno | Abnormality of the middle ear ossicles | 1.48e-03 | 25 | 12 | 2 | HP:0004452 | |
| HumanPheno | Abnormal heart valve physiology | 1.50e-03 | 403 | 12 | 5 | HP:0031653 | |
| HumanPheno | Scarring | 1.50e-03 | 102 | 12 | 3 | HP:0100699 | |
| HumanPheno | Abnormal 3rd finger morphology | 1.60e-03 | 26 | 12 | 2 | HP:0004150 | |
| HumanPheno | Abnormal tricuspid valve morphology | 1.64e-03 | 105 | 12 | 3 | HP:0031440 | |
| HumanPheno | Dermal translucency | 1.73e-03 | 27 | 12 | 2 | HP:0010648 | |
| HumanPheno | Malar flattening | 1.76e-03 | 240 | 12 | 4 | HP:0000272 | |
| HumanPheno | Blue sclerae | 1.77e-03 | 108 | 12 | 3 | HP:0000592 | |
| HumanPheno | Disproportionate short-limb short stature | 1.82e-03 | 109 | 12 | 3 | HP:0008873 | |
| HumanPheno | Severe short stature | 1.92e-03 | 111 | 12 | 3 | HP:0003510 | |
| HumanPheno | Hip dysplasia | 1.96e-03 | 247 | 12 | 4 | HP:0001385 | |
| HumanPheno | Abnormal malar bone morphology | 2.02e-03 | 249 | 12 | 4 | HP:0012369 | |
| HumanPheno | Abnormal zygomatic arch morphology | 2.05e-03 | 250 | 12 | 4 | HP:0005557 | |
| HumanPheno | Abnormal zygomatic bone morphology | 2.05e-03 | 250 | 12 | 4 | HP:0010668 | |
| HumanPheno | Abnormal tricuspid valve morphology | 2.13e-03 | 115 | 12 | 3 | HP:0001702 | |
| HumanPheno | Abnormal mitral valve morphology | 2.27e-03 | 257 | 12 | 4 | HP:0001633 | |
| MousePheno | impaired hearing | 9.57e-06 | 223 | 19 | 5 | MP:0006325 | |
| MousePheno | abnormal olecranon morphology | 1.05e-05 | 4 | 19 | 2 | MP:0030856 | |
| MousePheno | abnormal compact bone lamellar structure | 1.75e-05 | 5 | 19 | 2 | MP:0010970 | |
| MousePheno | decreased tendon stiffness | 1.75e-05 | 5 | 19 | 2 | MP:0003098 | |
| MousePheno | abnormal synovial joint morphology | 2.06e-05 | 124 | 19 | 4 | MP:0030804 | |
| MousePheno | abnormal tendon physiology | 2.62e-05 | 6 | 19 | 2 | MP:0030802 | |
| MousePheno | abnormal tendon stiffness | 2.62e-05 | 6 | 19 | 2 | MP:0003097 | |
| MousePheno | abnormal forelimb morphology | 9.25e-05 | 182 | 19 | 4 | MP:0000550 | |
| MousePheno | decreased bone trabecula number | 1.10e-04 | 70 | 19 | 3 | MP:0010869 | |
| MousePheno | abnormal hearing physiology | 1.50e-04 | 643 | 19 | 6 | MP:0001963 | |
| MousePheno | abnormal joint morphology | 1.51e-04 | 397 | 19 | 5 | MP:0002932 | |
| MousePheno | abnormal osteocyte morphology | 1.82e-04 | 15 | 19 | 2 | MP:0008753 | |
| MousePheno | abnormal ulna morphology | 1.89e-04 | 84 | 19 | 3 | MP:0005108 | |
| MousePheno | decreased percent body fat/body weight | 1.89e-04 | 84 | 19 | 3 | MP:0005459 | |
| MousePheno | abnormal ear physiology | 2.11e-04 | 684 | 19 | 6 | MP:0003878 | |
| MousePheno | abnormal joint mobility | 2.35e-04 | 17 | 19 | 2 | MP:0008069 | |
| MousePheno | abnormal somatic nervous system morphology | 2.57e-04 | 1025 | 19 | 7 | MP:0002752 | |
| MousePheno | abnormal osteocyte lacunocanalicular system morphology | 2.64e-04 | 18 | 19 | 2 | MP:0030485 | |
| MousePheno | small vertebral body | 2.95e-04 | 19 | 19 | 2 | MP:0004670 | |
| MousePheno | decreased bone volume | 3.17e-04 | 100 | 19 | 3 | MP:0010876 | |
| MousePheno | decreased embryonic neuroepithelium thickness | 3.28e-04 | 20 | 19 | 2 | MP:0012703 | |
| MousePheno | abnormal forelimb zeugopod morphology | 3.36e-04 | 102 | 19 | 3 | MP:0003855 | |
| MousePheno | delayed fertility | 3.62e-04 | 21 | 19 | 2 | MP:0002683 | |
| MousePheno | short limbs | 4.30e-04 | 111 | 19 | 3 | MP:0000547 | |
| MousePheno | abnormal primary cilium morphology | 4.65e-04 | 114 | 19 | 3 | MP:0013203 | |
| MousePheno | abnormal thoracic cage shape | 4.75e-04 | 24 | 19 | 2 | MP:0010099 | |
| MousePheno | abnormal limb joint morphology | 5.15e-04 | 25 | 19 | 2 | MP:0030805 | |
| MousePheno | abnormal trabecular bone morphology | 5.43e-04 | 289 | 19 | 4 | MP:0000130 | |
| MousePheno | fragile skeleton | 5.58e-04 | 26 | 19 | 2 | MP:0000061 | |
| MousePheno | decreased cochlear hair cell stereocilia number | 5.58e-04 | 26 | 19 | 2 | MP:0004523 | |
| MousePheno | abnormal compact bone thickness | 5.67e-04 | 122 | 19 | 3 | MP:0000134 | |
| MousePheno | abnormal cochlear inner hair cell morphology | 5.95e-04 | 124 | 19 | 3 | MP:0004393 | |
| MousePheno | short ribs | 6.48e-04 | 28 | 19 | 2 | MP:0004672 | |
| MousePheno | delayed vaginal opening | 6.48e-04 | 28 | 19 | 2 | MP:0002636 | |
| MousePheno | abnormal bone trabecula morphology | 7.46e-04 | 134 | 19 | 3 | MP:0010867 | |
| MousePheno | abnormal timing of vaginal opening | 7.95e-04 | 31 | 19 | 2 | MP:0020150 | |
| MousePheno | abnormal tendon morphology | 7.95e-04 | 31 | 19 | 2 | MP:0005503 | |
| MousePheno | abnormal ocular fundus morphology | 9.15e-04 | 1262 | 19 | 7 | MP:0002864 | |
| MousePheno | abnormal percent body fat/body weight | 9.19e-04 | 144 | 19 | 3 | MP:0005457 | |
| MousePheno | hearing/vestibular/ear phenotype | 9.46e-04 | 905 | 19 | 6 | MP:0005377 | |
| MousePheno | abnormal stationary movement | 9.76e-04 | 147 | 19 | 3 | MP:0001388 | |
| MousePheno | decreased bone ossification | 1.13e-03 | 37 | 19 | 2 | MP:0020040 | |
| MousePheno | decreased bone strength | 1.20e-03 | 38 | 19 | 2 | MP:0004991 | |
| MousePheno | abnormal susceptibility to hearing loss | 1.20e-03 | 38 | 19 | 2 | MP:0006334 | |
| MousePheno | abnormal cochlear outer hair cell morphology | 1.22e-03 | 159 | 19 | 3 | MP:0004399 | |
| MousePheno | abnormal chest morphology | 1.26e-03 | 39 | 19 | 2 | MP:0004134 | |
| MousePheno | abnormal cochlear hair cell physiology | 1.32e-03 | 40 | 19 | 2 | MP:0004432 | |
| MousePheno | abnormal scapula morphology | 1.32e-03 | 40 | 19 | 2 | MP:0000149 | |
| MousePheno | absent distortion product otoacoustic emissions | 1.39e-03 | 41 | 19 | 2 | MP:0004737 | |
| MousePheno | abnormal face size | 1.46e-03 | 42 | 19 | 2 | MP:0030063 | |
| MousePheno | abnormal compact bone morphology | 1.53e-03 | 172 | 19 | 3 | MP:0003797 | |
| MousePheno | abnormal bone volume | 1.56e-03 | 173 | 19 | 3 | MP:0010874 | |
| MousePheno | hemorrhage | 1.59e-03 | 664 | 19 | 5 | MP:0001914 | |
| MousePheno | abnormal blood urea nitrogen level | 1.64e-03 | 389 | 19 | 4 | MP:0005265 | |
| MousePheno | abnormal inner hair cell stereociliary bundle morphology | 1.67e-03 | 45 | 19 | 2 | MP:0004532 | |
| MousePheno | abnormal bone ossification | 1.74e-03 | 395 | 19 | 4 | MP:0008271 | |
| MousePheno | abnormal bone mineralization | 1.78e-03 | 181 | 19 | 3 | MP:0002896 | |
| MousePheno | abnormal hair cell physiology | 1.98e-03 | 49 | 19 | 2 | MP:0003879 | |
| MousePheno | delayed sexual maturation | 1.98e-03 | 49 | 19 | 2 | MP:0001938 | |
| MousePheno | abnormal uterus morphology | 2.08e-03 | 415 | 19 | 4 | MP:0001120 | |
| MousePheno | head bobbing | 2.14e-03 | 51 | 19 | 2 | MP:0001410 | |
| MousePheno | decreased bone mineralization | 2.14e-03 | 51 | 19 | 2 | MP:0020137 | |
| MousePheno | abnormal fibula morphology | 2.14e-03 | 51 | 19 | 2 | MP:0002187 | |
| MousePheno | abnormal anterior uvea morphology | 2.33e-03 | 199 | 19 | 3 | MP:0005194 | |
| MousePheno | abnormal nose morphology | 2.39e-03 | 201 | 19 | 3 | MP:0002233 | |
| MousePheno | decreased circulating potassium level | 2.40e-03 | 54 | 19 | 2 | MP:0005628 | |
| MousePheno | abnormal cochlear hair cell morphology | 2.43e-03 | 202 | 19 | 3 | MP:0002622 | |
| MousePheno | abnormal cilium morphology | 2.43e-03 | 433 | 19 | 4 | MP:0013202 | |
| MousePheno | abnormal cochlear sensory epithelium morphology | 2.60e-03 | 207 | 19 | 3 | MP:0003308 | |
| MousePheno | abnormal organ of Corti morphology | 2.68e-03 | 209 | 19 | 3 | MP:0000042 | |
| MousePheno | abnormal femur morphology | 2.86e-03 | 214 | 19 | 3 | MP:0000559 | |
| MousePheno | abnormal hair cell morphology | 2.86e-03 | 214 | 19 | 3 | MP:0000045 | |
| MousePheno | abnormal hindlimb stylopod morphology | 2.90e-03 | 215 | 19 | 3 | MP:0003856 | |
| MousePheno | decreased trabecular bone volume | 2.96e-03 | 60 | 19 | 2 | MP:0010879 | |
| MousePheno | abnormal gastrulation | 3.25e-03 | 469 | 19 | 4 | MP:0001695 | |
| Domain | Fib_collagen_C | 4.41e-07 | 11 | 27 | 3 | IPR000885 | |
| Domain | NC1_FIB | 4.41e-07 | 11 | 27 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 4.41e-07 | 11 | 27 | 3 | PD002078 | |
| Domain | COLFI | 4.41e-07 | 11 | 27 | 3 | SM00038 | |
| Domain | COLFI | 4.41e-07 | 11 | 27 | 3 | PF01410 | |
| Domain | Collagen | 2.46e-04 | 85 | 27 | 3 | PF01391 | |
| Domain | Collagen | 2.46e-04 | 85 | 27 | 3 | IPR008160 | |
| Domain | FHA | 7.43e-04 | 28 | 27 | 2 | SM00240 | |
| Domain | VWC | 7.43e-04 | 28 | 27 | 2 | PF00093 | |
| Domain | FHA_DOMAIN | 9.12e-04 | 31 | 27 | 2 | PS50006 | |
| Domain | FHA | 9.12e-04 | 31 | 27 | 2 | PF00498 | |
| Domain | FHA_dom | 1.23e-03 | 36 | 27 | 2 | IPR000253 | |
| Domain | - | 1.23e-03 | 36 | 27 | 2 | 2.60.200.20 | |
| Domain | VWFC_1 | 1.23e-03 | 36 | 27 | 2 | PS01208 | |
| Domain | VWC | 1.37e-03 | 38 | 27 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.37e-03 | 38 | 27 | 2 | PS50184 | |
| Domain | VWF_dom | 1.67e-03 | 42 | 27 | 2 | IPR001007 | |
| Domain | SMAD_FHA_domain | 2.55e-03 | 52 | 27 | 2 | IPR008984 | |
| Domain | Ank_2 | 3.59e-03 | 215 | 27 | 3 | PF12796 | |
| Domain | TSP_1 | 3.72e-03 | 63 | 27 | 2 | PF00090 | |
| Domain | TSP1_rpt | 3.96e-03 | 65 | 27 | 2 | IPR000884 | |
| Domain | TSP1 | 3.96e-03 | 65 | 27 | 2 | PS50092 | |
| Domain | TSP1 | 3.96e-03 | 65 | 27 | 2 | SM00209 | |
| Domain | Ank | 4.23e-03 | 228 | 27 | 3 | PF00023 | |
| Domain | - | 5.35e-03 | 248 | 27 | 3 | 1.25.40.20 | |
| Domain | ANK | 5.53e-03 | 251 | 27 | 3 | SM00248 | |
| Domain | ANK_REPEAT | 5.65e-03 | 253 | 27 | 3 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 5.71e-03 | 254 | 27 | 3 | IPR020683 | |
| Domain | ANK_REP_REGION | 5.71e-03 | 254 | 27 | 3 | PS50297 | |
| Domain | Ankyrin_rpt | 6.22e-03 | 262 | 27 | 3 | IPR002110 | |
| Domain | SAM | 7.14e-03 | 88 | 27 | 2 | SM00454 | |
| Domain | SAM_DOMAIN | 8.27e-03 | 95 | 27 | 2 | PS50105 | |
| Domain | SAM | 8.61e-03 | 97 | 27 | 2 | IPR001660 | |
| Domain | - | 1.02e-02 | 106 | 27 | 2 | 1.10.150.50 | |
| Domain | SAM/pointed | 1.23e-02 | 117 | 27 | 2 | IPR013761 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.98e-06 | 19 | 19 | 3 | MM15512 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 8.24e-06 | 30 | 19 | 3 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 8.24e-06 | 30 | 19 | 3 | MM15517 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.00e-05 | 32 | 19 | 3 | MM14924 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.14e-05 | 41 | 19 | 3 | MM15538 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.14e-05 | 41 | 19 | 3 | M27778 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.65e-05 | 44 | 19 | 3 | M27812 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 3.04e-05 | 46 | 19 | 3 | M198 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.24e-05 | 47 | 19 | 3 | MM14925 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 3.60e-05 | 7 | 19 | 2 | M48265 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.91e-05 | 50 | 19 | 3 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.66e-05 | 53 | 19 | 3 | MM14566 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 4.80e-05 | 8 | 19 | 2 | M48236 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.43e-05 | 59 | 19 | 3 | M27218 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 7.11e-05 | 61 | 19 | 3 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 7.11e-05 | 61 | 19 | 3 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 8.21e-05 | 64 | 19 | 3 | M26953 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 9.00e-05 | 66 | 19 | 3 | M18 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 9.42e-05 | 67 | 19 | 3 | M26999 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 9.42e-05 | 67 | 19 | 3 | MM15345 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.13e-04 | 12 | 19 | 2 | MM15093 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.13e-04 | 12 | 19 | 2 | MM15452 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.13e-04 | 12 | 19 | 2 | M27352 | |
| Pathway | WP_FOCAL_ADHESION | 1.26e-04 | 199 | 19 | 4 | M39402 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.27e-04 | 74 | 19 | 3 | M160 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.37e-04 | 76 | 19 | 3 | MM14573 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.37e-04 | 76 | 19 | 3 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.37e-04 | 76 | 19 | 3 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.54e-04 | 79 | 19 | 3 | M27643 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.79e-04 | 15 | 19 | 2 | M27161 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.85e-04 | 84 | 19 | 3 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.91e-04 | 85 | 19 | 3 | M16441 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 2.04e-04 | 16 | 19 | 2 | M9450 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.26e-04 | 90 | 19 | 3 | M631 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.60e-04 | 18 | 19 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.60e-04 | 18 | 19 | 2 | MM14882 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 2.90e-04 | 19 | 19 | 2 | M48230 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 2.90e-04 | 19 | 19 | 2 | M27221 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.54e-04 | 114 | 19 | 3 | MM14571 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 5.07e-04 | 25 | 19 | 2 | M274 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 5.92e-04 | 27 | 19 | 2 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 6.37e-04 | 28 | 19 | 2 | MM15957 | |
| Pathway | WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY | 6.37e-04 | 28 | 19 | 2 | M42541 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 7.32e-04 | 30 | 19 | 2 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 7.32e-04 | 30 | 19 | 2 | M39641 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 7.44e-04 | 135 | 19 | 3 | MM14781 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.27e-04 | 140 | 19 | 3 | M587 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 8.86e-04 | 33 | 19 | 2 | M39870 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 9.97e-04 | 35 | 19 | 2 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 9.97e-04 | 35 | 19 | 2 | M773 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 1.18e-03 | 38 | 19 | 2 | MM15456 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 1.24e-03 | 39 | 19 | 2 | M10735 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.24e-03 | 39 | 19 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.24e-03 | 39 | 19 | 2 | MM15165 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.50e-03 | 43 | 19 | 2 | M53 | |
| Pathway | WP_FOCAL_ADHESION | 1.90e-03 | 187 | 19 | 3 | MM15913 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.99e-03 | 190 | 19 | 3 | M8240 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 2.03e-03 | 50 | 19 | 2 | M48087 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.27e-03 | 199 | 19 | 3 | M7253 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 2.36e-03 | 54 | 19 | 2 | M42568 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA | 2.45e-03 | 55 | 19 | 2 | M41823 | |
| Pathway | PID_IL4_2PATHWAY | 3.30e-03 | 64 | 19 | 2 | M28 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.72e-03 | 68 | 19 | 2 | M27303 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 3.83e-03 | 69 | 19 | 2 | M48052 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.73e-03 | 258 | 19 | 3 | MM14572 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND | 4.74e-03 | 77 | 19 | 2 | M41822 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.18e-03 | 300 | 19 | 3 | M610 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 7.31e-03 | 302 | 19 | 3 | M39719 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 7.57e-03 | 98 | 19 | 2 | M27152 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 9.02e-03 | 326 | 19 | 3 | MM15917 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.30e-03 | 109 | 19 | 2 | MM15164 | |
| Pathway | WP_COMPREHENSIVE_IL17A_SIGNALING | 9.46e-03 | 110 | 19 | 2 | MM16642 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.63e-03 | 111 | 19 | 2 | M27416 | |
| Pathway | WP_BURN_WOUND_HEALING | 9.96e-03 | 113 | 19 | 2 | M42571 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.00e-02 | 339 | 19 | 3 | M39736 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.56e-02 | 143 | 19 | 2 | M27275 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.76e-02 | 418 | 19 | 3 | MM15587 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 23546968 | ||
| Pubmed | Mutations in collagen genes: causes of rare and some common diseases in humans. | 4.17e-10 | 3 | 27 | 3 | 2010058 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 12200454 | ||
| Pubmed | Immunohistochemical characteristics of developing mandibular angle in fetal mice. | 1.67e-09 | 4 | 27 | 3 | 16356873 | |
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 9880238 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 10633870 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 16537906 | ||
| Pubmed | 8.33e-09 | 6 | 27 | 3 | 9101290 | ||
| Pubmed | Development and regeneration of the neonatal digit tip in mice. | 8.33e-09 | 6 | 27 | 3 | 18234177 | |
| Pubmed | 1.46e-08 | 7 | 27 | 3 | 10072783 | ||
| Pubmed | 2.33e-08 | 8 | 27 | 3 | 27664939 | ||
| Pubmed | Filamin B mutations cause chondrocyte defects in skeletal development. | 2.33e-08 | 8 | 27 | 3 | 17510210 | |
| Pubmed | Type XIII collagen strongly affects bone formation in transgenic mice. | 2.33e-08 | 8 | 27 | 3 | 16007336 | |
| Pubmed | 2.33e-08 | 8 | 27 | 3 | 26553654 | ||
| Pubmed | 3.49e-08 | 9 | 27 | 3 | 8900172 | ||
| Pubmed | 3.49e-08 | 9 | 27 | 3 | 31199918 | ||
| Pubmed | Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. | 4.99e-08 | 10 | 27 | 3 | 15162503 | |
| Pubmed | Ucma is not necessary for normal development of the mouse skeleton. | 4.99e-08 | 10 | 27 | 3 | 22155508 | |
| Pubmed | VEGF stimulates intramembranous bone formation during craniofacial skeletal development. | 4.99e-08 | 10 | 27 | 3 | 26899202 | |
| Pubmed | Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. | 4.99e-08 | 10 | 27 | 3 | 16109715 | |
| Pubmed | 6.86e-08 | 11 | 27 | 3 | 35988140 | ||
| Pubmed | Hsp and chaperone distribution during endochondral bone development in mouse embryo. | 6.86e-08 | 11 | 27 | 3 | 9880236 | |
| Pubmed | 6.86e-08 | 11 | 27 | 3 | 24248941 | ||
| Pubmed | 9.14e-08 | 12 | 27 | 3 | 32002646 | ||
| Pubmed | 1.19e-07 | 13 | 27 | 3 | 19653325 | ||
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 1.19e-07 | 13 | 27 | 3 | 11839810 | |
| Pubmed | 1.19e-07 | 13 | 27 | 3 | 31961823 | ||
| Pubmed | 1.51e-07 | 14 | 27 | 3 | 30459452 | ||
| Pubmed | Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. | 1.51e-07 | 14 | 27 | 3 | 17194222 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 1.89e-07 | 15 | 27 | 3 | 9832566 | |
| Pubmed | 1.89e-07 | 15 | 27 | 3 | 38018454 | ||
| Pubmed | Enhanced BMP signaling leads to enlarged nasal cartilage formation in mice. | 2.32e-07 | 16 | 27 | 3 | 37640003 | |
| Pubmed | 2.82e-07 | 17 | 27 | 3 | 21185280 | ||
| Pubmed | SIK3 is essential for chondrocyte hypertrophy during skeletal development in mice. | 2.82e-07 | 17 | 27 | 3 | 22318228 | |
| Pubmed | Loss of Foxc1 and Foxc2 function in chondroprogenitor cells disrupts endochondral ossification. | 2.82e-07 | 17 | 27 | 3 | 34331943 | |
| Pubmed | 2.82e-07 | 17 | 27 | 3 | 24930703 | ||
| Pubmed | 4.01e-07 | 19 | 27 | 3 | 15866164 | ||
| Pubmed | Site-1 protease is essential for endochondral bone formation in mice. | 4.01e-07 | 19 | 27 | 3 | 18025304 | |
| Pubmed | 4.01e-07 | 19 | 27 | 3 | 15689378 | ||
| Pubmed | 4.71e-07 | 20 | 27 | 3 | 19853894 | ||
| Pubmed | Site-1 protease regulates skeletal stem cell population and osteogenic differentiation in mice. | 4.71e-07 | 20 | 27 | 3 | 29437042 | |
| Pubmed | 5.50e-07 | 21 | 27 | 3 | 23034633 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 11358497 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 11143996 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21602843 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 34727246 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15211650 | ||
| Pubmed | Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer. | 5.80e-07 | 2 | 27 | 2 | 27894325 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19387081 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 6320112 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 35915937 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26927310 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 10408781 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 2777764 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 32335875 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 20736093 | ||
| Pubmed | [Analysis of COL1A1 and COL1A2 gene variants in two fetuses with osteogenesis imperfecta]. | 5.80e-07 | 2 | 27 | 2 | 37368383 | |
| Pubmed | Streptococcal protein FOG, a novel matrix adhesin interacting with collagen I in vivo. | 5.80e-07 | 2 | 27 | 2 | 16278217 | |
| Pubmed | Osteogenesis imperfecta: comparison of molecular defects with bone histological changes. | 5.80e-07 | 2 | 27 | 2 | 7520724 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 8723681 | ||
| Pubmed | Unequal Impact of COL1A1 and COL1A2 Variants on Dentinogenesis Imperfecta. | 5.80e-07 | 2 | 27 | 2 | 36951356 | |
| Pubmed | Effects of GABA on the expression of type I collagen gene in normal human dermal fibroblasts. | 5.80e-07 | 2 | 27 | 2 | 27691923 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 17211858 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 36853784 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 8094076 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 32166892 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 5529814 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 35909573 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 8204907 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27519266 | ||
| Pubmed | Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer. | 5.80e-07 | 2 | 27 | 2 | 21163673 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21193410 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 9443882 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27090748 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15241796 | ||
| Pubmed | Mutation spectrum of COL1A1 and COL1A2 genes in Indian patients with osteogenesis imperfecta. | 5.80e-07 | 2 | 27 | 2 | 24668929 | |
| Pubmed | Prenatal Cases Reflect the Complexity of the COL1A1/2 Associated Osteogenesis Imperfecta. | 5.80e-07 | 2 | 27 | 2 | 36140746 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 7945553 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19929435 | ||
| Pubmed | [Relationship of collagen type I alpha 1 and alpha 2 gene polymorphisms with bone mineral density]. | 5.80e-07 | 2 | 27 | 2 | 16864092 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 9239397 | ||
| Pubmed | Evidence for a relationship between Ehlers-Danlos type VII C in humans and bovine dermatosparaxis. | 5.80e-07 | 2 | 27 | 2 | 1303238 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 6857446 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 20087402 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 8552450 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 8020944 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 28528406 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 30604926 | ||
| Pubmed | Early type I collagen deposition is associated with prognosis in biliary atresia. | 5.80e-07 | 2 | 27 | 2 | 26452701 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 8097422 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27454992 | ||
| Pubmed | Regional chromosome mapping of human collagen genes alpha 2(I) and alpha 1(I) (COLIA2 and COLIA1). | 5.80e-07 | 2 | 27 | 2 | 3857213 | |
| Pubmed | No evidence for disturbed COL1A1 and A2 expression in otosclerosis. | 5.80e-07 | 2 | 27 | 2 | 22130917 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 34902613 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 1874719 | ||
| Pubmed | Clinical severity prediction in children with osteogenesis imperfecta caused by COL1A1/2 defects. | 5.80e-07 | 2 | 27 | 2 | 35044492 | |
| Pubmed | Differential unfolding of alpha1 and alpha2 chains in type I collagen and collagenolysis. | 5.80e-07 | 2 | 27 | 2 | 18644377 | |
| Pubmed | COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. | 5.80e-07 | 2 | 27 | 2 | 21344539 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 31876392 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23692737 | ||
| Interaction | TGFBI interactions | 4.30e-06 | 25 | 26 | 3 | int:TGFBI | |
| Interaction | BGN interactions | 7.56e-06 | 30 | 26 | 3 | int:BGN | |
| Interaction | PDGFA interactions | 9.22e-06 | 32 | 26 | 3 | int:PDGFA | |
| Interaction | SPARC interactions | 7.90e-05 | 65 | 26 | 3 | int:SPARC | |
| Interaction | NEK8 interactions | 8.64e-05 | 67 | 26 | 3 | int:NEK8 | |
| Interaction | MMP9 interactions | 8.64e-05 | 67 | 26 | 3 | int:MMP9 | |
| Interaction | COL9A1 interactions | 1.24e-04 | 13 | 26 | 2 | int:COL9A1 | |
| Interaction | TMEM44 interactions | 1.66e-04 | 15 | 26 | 2 | int:TMEM44 | |
| Interaction | MMP2 interactions | 1.88e-04 | 87 | 26 | 3 | int:MMP2 | |
| Interaction | FGF7 interactions | 1.90e-04 | 16 | 26 | 2 | int:FGF7 | |
| Interaction | PDGFB interactions | 1.95e-04 | 88 | 26 | 3 | int:PDGFB | |
| Interaction | RNF144A interactions | 2.15e-04 | 91 | 26 | 3 | int:RNF144A | |
| Interaction | CBLL2 interactions | 3.00e-04 | 20 | 26 | 2 | int:CBLL2 | |
| Cytoband | Xq13.1 | 3.69e-04 | 48 | 27 | 2 | Xq13.1 | |
| GeneFamily | Collagens | 1.02e-05 | 46 | 17 | 3 | 490 | |
| GeneFamily | Ankyrin repeat domain containing | 1.40e-03 | 242 | 17 | 3 | 403 | |
| GeneFamily | Sterile alpha motif domain containing | 3.04e-03 | 88 | 17 | 2 | 760 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 6.24e-06 | 35 | 27 | 3 | MM17054 | |
| Coexpression | NABA_COLLAGENS | 1.17e-05 | 43 | 27 | 3 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 1.26e-05 | 44 | 27 | 3 | M3005 | |
| Coexpression | GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN | 4.65e-05 | 196 | 27 | 4 | M10002 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 6.02e-05 | 74 | 27 | 3 | M4479 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 6.02e-05 | 74 | 27 | 3 | M13547 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 1.11e-04 | 91 | 27 | 3 | M40180 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 1.43e-04 | 99 | 27 | 3 | M39152 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 1.55e-04 | 18 | 27 | 2 | M13796 | |
| Coexpression | KANG_AR_TARGETS_DN | 1.55e-04 | 18 | 27 | 2 | M2225 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 1.55e-04 | 18 | 27 | 2 | MM1241 | |
| Coexpression | KANG_AR_TARGETS_DN | 1.55e-04 | 18 | 27 | 2 | MM892 | |
| Coexpression | LIAO_METASTASIS | 2.02e-04 | 540 | 27 | 5 | M13809 | |
| Coexpression | DESCARTES_MAIN_FETAL_STROMAL_CELLS | 2.33e-04 | 22 | 27 | 2 | M40074 | |
| Coexpression | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN | 3.27e-04 | 26 | 27 | 2 | M1623 | |
| Coexpression | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN | 3.27e-04 | 26 | 27 | 2 | MM1193 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 3.73e-04 | 137 | 27 | 3 | M40313 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 4.05e-04 | 141 | 27 | 3 | M10381 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 4.08e-04 | 29 | 27 | 2 | MM17055 | |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 4.08e-04 | 29 | 27 | 2 | M7581 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 4.49e-04 | 146 | 27 | 3 | MM973 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 4.49e-04 | 146 | 27 | 3 | M40222 | |
| Coexpression | DESCARTES_FETAL_HEART_STROMAL_CELLS | 5.62e-04 | 34 | 27 | 2 | M40199 | |
| Coexpression | HATADA_METHYLATED_IN_LUNG_CANCER_UP | 5.69e-04 | 377 | 27 | 4 | M19508 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 5.86e-04 | 681 | 27 | 5 | M39175 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 6.08e-04 | 162 | 27 | 3 | M45037 | |
| Coexpression | GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 6.53e-04 | 166 | 27 | 3 | M9100 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 6.87e-04 | 169 | 27 | 3 | M9102 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 7.78e-04 | 40 | 27 | 2 | M1574 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN | 9.94e-04 | 192 | 27 | 3 | M4296 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN | 1.01e-03 | 193 | 27 | 3 | M4284 | |
| Coexpression | GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP | 1.01e-03 | 193 | 27 | 3 | M3303 | |
| Coexpression | GSE29618_BCELL_VS_MDC_UP | 1.02e-03 | 194 | 27 | 3 | M4943 | |
| Coexpression | JONES_OVARY_THECA | 1.03e-03 | 46 | 27 | 2 | M48349 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 1.03e-03 | 46 | 27 | 2 | MM670 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 1.03e-03 | 46 | 27 | 2 | MM544 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 1.07e-03 | 47 | 27 | 2 | M1399 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.07e-03 | 47 | 27 | 2 | M7585 | |
| Coexpression | GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN | 1.09e-03 | 198 | 27 | 3 | M5545 | |
| Coexpression | HAY_BONE_MARROW_NEUTROPHIL | 1.10e-03 | 450 | 27 | 4 | M39203 | |
| Coexpression | GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP | 1.10e-03 | 199 | 27 | 3 | M8477 | |
| Coexpression | GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP | 1.10e-03 | 199 | 27 | 3 | M6934 | |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP | 1.10e-03 | 199 | 27 | 3 | M7821 | |
| Coexpression | GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP | 1.12e-03 | 200 | 27 | 3 | M6369 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 1.12e-03 | 200 | 27 | 3 | M9459 | |
| Coexpression | GSE3039_CD4_TCELL_VS_B2_BCELL_UP | 1.12e-03 | 200 | 27 | 3 | M6462 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN | 1.12e-03 | 200 | 27 | 3 | M8496 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP | 1.12e-03 | 200 | 27 | 3 | M4528 | |
| Coexpression | GSE27786_BCELL_VS_NKCELL_UP | 1.12e-03 | 200 | 27 | 3 | M4805 | |
| Coexpression | GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_UP | 1.12e-03 | 200 | 27 | 3 | M9294 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN | 1.12e-03 | 200 | 27 | 3 | M9296 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_HSC_UP | 1.12e-03 | 200 | 27 | 3 | M7040 | |
| Coexpression | CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL | 1.12e-03 | 48 | 27 | 2 | M39318 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.33e-06 | 193 | 27 | 4 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 5.67e-06 | 196 | 27 | 4 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 5.67e-06 | 196 | 27 | 4 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.90e-06 | 198 | 27 | 4 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.90e-06 | 198 | 27 | 4 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-06 | 200 | 27 | 4 | cbf6a6c3db88bac37bd084a3a914b12b3af524eb | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.08e-04 | 154 | 27 | 3 | 44d4d99b08216c0901e3bc32743fa0a8b85b5149 | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 1.24e-04 | 161 | 27 | 3 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 163 | 27 | 3 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 163 | 27 | 3 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.30e-04 | 164 | 27 | 3 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.30e-04 | 164 | 27 | 3 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 27 | 3 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 166 | 27 | 3 | 6a65dff1333f39ec8c584e6df04b8c1e7f1c8946 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.40e-04 | 168 | 27 | 3 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.40e-04 | 168 | 27 | 3 | 26aa96b2b547d11941cb803995ea3d302ee0518c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 169 | 27 | 3 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 169 | 27 | 3 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 169 | 27 | 3 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 171 | 27 | 3 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.48e-04 | 171 | 27 | 3 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 171 | 27 | 3 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.48e-04 | 171 | 27 | 3 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Neutrophil|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 173 | 27 | 3 | dfa56753319c92ae5b337793c4d6d5f70afce546 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 173 | 27 | 3 | 11e95a60b5f6f07f27154a23203bac431e7528c6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-04 | 174 | 27 | 3 | 9d22a554617a93701d0945de63cc3e7b24322c40 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 1.58e-04 | 175 | 27 | 3 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.61e-04 | 176 | 27 | 3 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 177 | 27 | 3 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 177 | 27 | 3 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 177 | 27 | 3 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.66e-04 | 178 | 27 | 3 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.66e-04 | 178 | 27 | 3 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.69e-04 | 179 | 27 | 3 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.69e-04 | 179 | 27 | 3 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-04 | 179 | 27 | 3 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-04 | 180 | 27 | 3 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-04 | 180 | 27 | 3 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.72e-04 | 180 | 27 | 3 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-04 | 181 | 27 | 3 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-04 | 181 | 27 | 3 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.77e-04 | 182 | 27 | 3 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 182 | 27 | 3 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.77e-04 | 182 | 27 | 3 | dc32f8f6a3b13918eb8e93c018f5823d86344080 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 182 | 27 | 3 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.80e-04 | 183 | 27 | 3 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-04 | 183 | 27 | 3 | af14da45267261e775dd6dab7a4c359b181e46f1 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-04 | 183 | 27 | 3 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-04 | 183 | 27 | 3 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 1.80e-04 | 183 | 27 | 3 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-04 | 183 | 27 | 3 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.83e-04 | 184 | 27 | 3 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.83e-04 | 184 | 27 | 3 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | mild-Myeloid-mDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.83e-04 | 184 | 27 | 3 | 8b37c00d59d9992d3b43268991da7bb94646c70e | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.83e-04 | 184 | 27 | 3 | 7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-04 | 185 | 27 | 3 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.86e-04 | 185 | 27 | 3 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-04 | 185 | 27 | 3 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-04 | 185 | 27 | 3 | 2c1f14f77faeee2acb388d997c5a27a7fef79be1 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-04 | 185 | 27 | 3 | 37db8e0b1f59274227f6fc2362167eb44bd080ef | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 1.89e-04 | 186 | 27 | 3 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 187 | 27 | 3 | 6f47a80e612b320f571210483e62ff5db2a8ea43 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 187 | 27 | 3 | f0c4d93f75615e570e4465fd622e3124189618a1 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.92e-04 | 187 | 27 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 187 | 27 | 3 | 3ff57da09ed8394913fb683669d7bff84a936623 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.92e-04 | 187 | 27 | 3 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 1.95e-04 | 188 | 27 | 3 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-04 | 188 | 27 | 3 | aa46073e2940dc1d2020b2e259bf0fc06cb990ee | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.95e-04 | 188 | 27 | 3 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.95e-04 | 188 | 27 | 3 | 04814b78da936a51a497e23060d19ca0d619e250 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 1.95e-04 | 188 | 27 | 3 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.98e-04 | 189 | 27 | 3 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.98e-04 | 189 | 27 | 3 | 0fe8901e10c619c93b7788792da1706a32102c6e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.98e-04 | 189 | 27 | 3 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.01e-04 | 190 | 27 | 3 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.01e-04 | 190 | 27 | 3 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.01e-04 | 190 | 27 | 3 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.01e-04 | 190 | 27 | 3 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.01e-04 | 190 | 27 | 3 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | 9d3fa8d8138700640cc7927521c7635299df697d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-04 | 191 | 27 | 3 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-04 | 191 | 27 | 3 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-04 | 191 | 27 | 3 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 191 | 27 | 3 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | d04ed1e04b8cb904237d8e8388fe7740c724237b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-04 | 191 | 27 | 3 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 191 | 27 | 3 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | T_cells-Central_memory_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.04e-04 | 191 | 27 | 3 | 25dd538d6a361bd3367c8a1c0dfc9e7003061af3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 192 | 27 | 3 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | B_cells-Memory_B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.08e-04 | 192 | 27 | 3 | eef591095921ede098f41a2b81897b18915bb753 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-04 | 192 | 27 | 3 | dc4b4e16e6eb212e45fb70695afd1c7e91027407 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.11e-04 | 193 | 27 | 3 | 2b80991e7ba7640f7ab2139d30e4c54d8e533862 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.11e-04 | 193 | 27 | 3 | 90cfc34c2d0d7c70f071703d35db1d6037961481 | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 2.11e-04 | 193 | 27 | 3 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | B_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.11e-04 | 193 | 27 | 3 | b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | control-Myeloid-Neutrophils_3|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.11e-04 | 193 | 27 | 3 | 56daf3c59a124dd068af5409113913d9ee81a454 | |
| Computational | Neighborhood of CDH11 | 6.11e-04 | 25 | 16 | 2 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 1.27e-03 | 36 | 16 | 2 | GNF2_PTX3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.44e-03 | 50 | 16 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.44e-03 | 50 | 16 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_29_NPC_OPC | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.44e-03 | 50 | 16 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Drug | Collagenase | 5.94e-09 | 4 | 27 | 3 | DB00048 | |
| Drug | ascorbate-2-phosphate | 6.70e-07 | 15 | 27 | 3 | ctd:C011669 | |
| Drug | 5'-methylthioadenosine | 1.35e-06 | 2 | 27 | 2 | ctd:C008500 | |
| Drug | isodesmosine | 7.92e-06 | 33 | 27 | 3 | CID000013811 | |
| Drug | diacetylrhein | 8.11e-06 | 4 | 27 | 2 | ctd:C025292 | |
| Drug | GK-101 | 1.03e-05 | 36 | 27 | 3 | CID000161853 | |
| Drug | BPAT-143 | 2.03e-05 | 6 | 27 | 2 | CID000146249 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 2.03e-05 | 6 | 27 | 2 | ctd:C502971 | |
| Drug | AG-H-50319 | 2.03e-05 | 6 | 27 | 2 | CID011819195 | |
| Drug | Madecassol | 2.18e-05 | 46 | 27 | 3 | CID000108062 | |
| Drug | d-indobufen | 2.81e-05 | 50 | 27 | 3 | CID000044562 | |
| Drug | Oi-1 | 2.83e-05 | 7 | 27 | 2 | CID000448053 | |
| Drug | ridogrel | 3.16e-05 | 52 | 27 | 3 | CID005362391 | |
| Drug | NSC49633 | 3.35e-05 | 53 | 27 | 3 | CID000023340 | |
| Drug | desmosine | 3.35e-05 | 53 | 27 | 3 | CID000025435 | |
| Drug | 3,4,5-trihydroxy-N-(4-(thiazol-2-ylsulfamoyl)-phenyl)-benzamide | 3.78e-05 | 8 | 27 | 2 | ctd:C000594958 | |
| Drug | dihydrocytochalasin B | 4.39e-05 | 58 | 27 | 3 | CID000003064 | |
| Drug | 4-hydroxymercuribenzoate | 4.85e-05 | 9 | 27 | 2 | ctd:C030601 | |
| Drug | AC1LAKND | 5.37e-05 | 62 | 27 | 3 | CID000470146 | |
| Drug | 4-aminoazobenzene | 6.47e-05 | 66 | 27 | 3 | CID000006051 | |
| Drug | BAPN | 8.06e-05 | 71 | 27 | 3 | CID000001647 | |
| Drug | malotilate | 8.06e-05 | 71 | 27 | 3 | CID000004006 | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 8.16e-05 | 197 | 27 | 4 | 3832_UP | |
| Drug | Sulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 8.16e-05 | 197 | 27 | 4 | 5528_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; HL60; HT_HG-U133A | 8.32e-05 | 198 | 27 | 4 | 6200_UP | |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; PC3; HT_HG-U133A | 8.65e-05 | 200 | 27 | 4 | 5730_UP | |
| Drug | L-3,4-dehydroproline | 8.75e-05 | 73 | 27 | 3 | CID000094284 | |
| Drug | AC1NMZ1B | 9.49e-05 | 75 | 27 | 3 | CID005034185 | |
| Drug | strontium ranelate | 1.03e-04 | 77 | 27 | 3 | CID006918182 | |
| Drug | halofuginone lactate | 1.38e-04 | 85 | 27 | 3 | CID000062891 | |
| Drug | 4-hydroxyproline | 1.69e-04 | 91 | 27 | 3 | CID000000825 | |
| Drug | Rgd Peptide | 1.72e-04 | 239 | 27 | 4 | CID000104802 | |
| Drug | alizarin red S | 1.91e-04 | 95 | 27 | 3 | CID000008534 | |
| Drug | Taylor's blue | 2.05e-04 | 18 | 27 | 2 | CID000123898 | |
| Drug | deoxypyridinoline | 2.10e-04 | 98 | 27 | 3 | CID000105071 | |
| Drug | pyridinoline | 2.16e-04 | 99 | 27 | 3 | CID000105068 | |
| Drug | didecyldimethylammonium | 2.29e-04 | 19 | 27 | 2 | ctd:C027118 | |
| Drug | AC1L9N61 | 2.36e-04 | 102 | 27 | 3 | CID000449471 | |
| Drug | ticlopidine | 2.43e-04 | 103 | 27 | 3 | CID000005472 | |
| Drug | 351A | 2.54e-04 | 20 | 27 | 2 | CID000122144 | |
| Drug | S-Adenosylhomocysteine | 2.54e-04 | 20 | 27 | 2 | ctd:D012435 | |
| Drug | hydroxylysine | 2.87e-04 | 109 | 27 | 3 | CID000001029 | |
| Drug | bromochloroacetic acid | 2.87e-04 | 109 | 27 | 3 | ctd:C099813 | |
| Drug | AC1L1C2F | 2.95e-04 | 110 | 27 | 3 | CID000001711 | |
| Drug | Sudan II | 3.19e-04 | 113 | 27 | 3 | CID005354447 | |
| Drug | PPACK | 3.19e-04 | 113 | 27 | 3 | CID003036757 | |
| Drug | AC1L9732 | 3.28e-04 | 114 | 27 | 3 | CID000439300 | |
| Drug | Tranilast sodium | 3.36e-04 | 115 | 27 | 3 | CID000005527 | |
| Drug | ABT-100 | 3.68e-04 | 24 | 27 | 2 | CID006451154 | |
| Drug | exoenzyme C3, Clostridium botulinum | 4.00e-04 | 25 | 27 | 2 | ctd:C063007 | |
| Drug | farnesol pyrophosphate | 4.19e-04 | 124 | 27 | 3 | CID000000706 | |
| Drug | Selara | 4.29e-04 | 125 | 27 | 3 | CID000150310 | |
| Drug | fulvic acid | 4.67e-04 | 27 | 27 | 2 | ctd:C005023 | |
| Drug | [(2R,3R,4R,5S,6R)-2-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)-3-[(2-tritioacetyl)amino]oxan-4-yl] (3R)-3-hydroxydecanoate | 5.02e-04 | 28 | 27 | 2 | CID011650719 | |
| Drug | DMSe | 5.03e-04 | 132 | 27 | 3 | CID000020796 | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 8.06e-07 | 2 | 27 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 8.06e-07 | 2 | 27 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 8.06e-07 | 2 | 27 | 2 | C0268345 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 8.06e-07 | 2 | 27 | 2 | C4551623 | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 8.06e-07 | 2 | 27 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 8.06e-07 | 2 | 27 | 2 | 166220 | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 8.06e-07 | 2 | 27 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 8.06e-07 | 2 | 27 | 2 | cv:C0268362 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 8.06e-07 | 2 | 27 | 2 | 166210 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 8.06e-07 | 2 | 27 | 2 | cv:C0268358 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 8.06e-07 | 2 | 27 | 2 | 259420 | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 2.42e-06 | 3 | 27 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 2.42e-06 | 3 | 27 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | OSTEOPOROSIS | 4.83e-06 | 4 | 27 | 2 | 166710 | |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 8.05e-06 | 5 | 27 | 2 | C0268358 | |
| Disease | Lobstein Disease | 8.05e-06 | 5 | 27 | 2 | C0023931 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 8.05e-06 | 5 | 27 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos Syndrome | 8.05e-06 | 5 | 27 | 2 | C0013720 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 1.21e-05 | 6 | 27 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | Osteoporosis | 1.21e-05 | 6 | 27 | 2 | cv:C0029456 | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 3.61e-05 | 10 | 27 | 2 | C0268363 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 4.41e-05 | 11 | 27 | 2 | C0268362 | |
| Disease | basophil percentage of granulocytes | 5.98e-05 | 83 | 27 | 3 | EFO_0007995 | |
| Disease | Osteogenesis Imperfecta | 6.25e-05 | 13 | 27 | 2 | C0029434 | |
| Disease | basophil percentage of leukocytes | 6.78e-05 | 243 | 27 | 4 | EFO_0007992 | |
| Disease | Oral Submucous Fibrosis | 1.22e-04 | 18 | 27 | 2 | C0029172 | |
| Disease | Osteogenesis imperfecta | 1.68e-04 | 21 | 27 | 2 | cv:C0029434 | |
| Disease | tooth agenesis | 1.84e-04 | 22 | 27 | 2 | EFO_0005410 | |
| Disease | Sensorineural Hearing Loss (disorder) | 2.02e-04 | 23 | 27 | 2 | C0018784 | |
| Disease | neutrophil percentage of leukocytes | 2.06e-04 | 610 | 27 | 5 | EFO_0007990 | |
| Disease | Heart valve disease | 2.59e-04 | 26 | 27 | 2 | C0018824 | |
| Disease | lymphocyte percentage of leukocytes | 3.06e-04 | 665 | 27 | 5 | EFO_0007993 | |
| Disease | Hereditary hearing loss and deafness | 3.18e-04 | 146 | 27 | 3 | cv:C0236038 | |
| Disease | osteoporosis (is_implicated_in) | 3.69e-04 | 31 | 27 | 2 | DOID:11476 (is_implicated_in) | |
| Disease | cortical thickness | 4.26e-04 | 1113 | 27 | 6 | EFO_0004840 | |
| Disease | macula measurement | 6.75e-04 | 189 | 27 | 3 | EFO_0008375 | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 7.79e-04 | 45 | 27 | 2 | DOID:5199 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKRPCNSQPCSQRPD | 1016 | Q6UY14 | |
| PERRSPGSPVCRADK | 141 | Q86VQ1 | |
| CEASNPRPEKGDRRP | 141 | Q9Y4F5 | |
| SDSEEKPCAKPRRPQ | 1581 | Q9P2D1 | |
| SPEGSRKNPARTCRD | 1271 | P02458 | |
| PAGRKRERPERCSSS | 31 | Q9P258 | |
| KFRRQSEDPSCPNER | 251 | Q4KMQ2 | |
| PRAERKCPRIAPADS | 151 | Q8IYF1 | |
| RSPARDPRTTPACRD | 406 | Q5VZ46 | |
| APRPSDKPCADSERA | 26 | O75949 | |
| TPEGSRKNPARTCRD | 1151 | P08123 | |
| EESPQPRRKRQPSSS | 136 | Q96C57 | |
| KDRCRRKSCRNPPDP | 96 | P17927 | |
| DESCPAPQRQRPCRK | 246 | Q6ZW76 | |
| AEQQKGRRSPDSCRP | 606 | Q9Y283 | |
| LPRDSPRRNKEGCTS | 1431 | Q9H1H9 | |
| SEKPAQSLDPSRRPR | 581 | Q9BZL4 | |
| SEQPSKRPRCDDSPR | 6 | Q9Y3Z3 | |
| KRPRCDDSPRTPSNT | 11 | Q9Y3Z3 | |
| PAFVKNTCPSRPRER | 616 | Q8NE18 | |
| DSPRTSCARRDDPRA | 646 | Q9H2D6 | |
| EEPRKPASAPSEACR | 506 | Q9Y4F9 | |
| RSPEGSRKNPARTCR | 1246 | P02452 | |
| RKCAARDPEDRIPSP | 6 | Q9Y3A4 | |
| NRSREACKDRTPPPR | 86 | Q5JNZ5 | |
| VGRSRPKANSRPDCD | 671 | Q9Y4R7 | |
| ERAKPRARSTPSNPD | 3241 | Q96JG9 | |
| KRCPDSTRPETVRPC | 716 | Q9C0I4 | |
| SPIRSDEPACRAKPD | 366 | Q9NUE0 |